Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (379)	2/28/2000 11:59:00 PM
From: JFitnich	Read Replies (1) \| Respond to of 427

To the board, VCall has an interesting interview with D. Hines from "one of the Florida boys", D. Hines from Avalon Research. Gives his side of the CLPA debate. And what a debate! Interesting because it casts a look at FDA trial design. Both from Co. perspective and Avalon's. He comes off pompous. His "retail investors are beneath the intelligence level of our firm" rant gets tiresome and actually insulting in some spots. Whatever. To each his own. It was still intriguing to hear the other side of the story. Not long or short CLPA and have never owned it. Just a casual observer. www.vcall.com JF